SEC Filing Summary: Midatech Pharma PLC (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by Midatech Pharma PLC, a foreign private issuer, for the month of March 2020. The filing date is March 2, 2020. The registrant is headquartered in Cardiff, United Kingdom. Note: The request metadata references "Biodexa Pharmaceuticals Plc," but the filing text explicitly identifies the registrant as "Midatech Pharma PLC."
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a notice of a corporate action and does not contain financial statements or performance metrics.
Material Changes
The filing incorporates by reference a press release dated March 2, 2020, detailing the following material corporate actions:
- Results of a General Meeting.
- A change in the American Depositary Receipt (ADR) ratio.
- Updates regarding total voting rights.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, specific risks, contingencies, or unusual items. The content is limited to the announcement of the General Meeting results and the ADR ratio adjustment.
Investor Verification Checklist
- Verify the specific details of the ADR ratio change and its effective date.
- Confirm the outcomes of the General Meeting referenced in the attached press release.
- Review the updated total voting rights structure for shareholders.
- Clarify the discrepancy between the request metadata (Biodexa) and the filing registrant (Midatech).